FABP5 and prostate carcinoma: Among FABPs, FABP5 was shown to be overexpressed in several tumor types and its expression level was shown to be associated with the growth and metastasis of several cancer types including prostate cancer, intrahepatic cholangiocarcinoma, colorectal cancer and cervical cancer [56,57,58,59].